GGrantIndex
Sort

261,768 grants matching gene therapy

Investigations of Methylmalonic Acidemia and Related Disorders

$1,574,328
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2020 · HG

Disruption of Transcription Networks in Esophageal Adenocarcinoma Tumorigenesis

$1,574,246
Wael El-Rifai · University Of Miami School Of Medicine · P01 · FY2022 · CA

Genetic Analysis of the Breast Tumor Microenvironment

$1,574,165
Michael C Ostrowski · Ohio State University · P01 · FY2012 · CA

Nephrotic Syndrome Rare Disease Clinical Research Network III

$1,574,136
Matthias Kretzler · University Of Michigan At Ann Arbor · U54 · FY2020 · DK

Sen Paul D. Wellstone Muscular Dystrophy Cooperative Research Center: Seattle

$1,574,098
Jeffrey S Chamberlain · University Of Washington · U54 · FY2015 · AR

Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL

$1,573,916
Jonathan L. Haines · Case Western Reserve University · R01 · FY2024 · AG

Translating molecular signal pathways to orthopaedic trauma care

$1,573,860
Randy N Rosier · University Of Rochester · P50 · FY2006 · AR

Fluorescent Redox Indicators to Image Oxidative Stress in Alzheimer's Disease

$1,573,788
Huiwang Ai · University Of Virginia · RF1 · FY2022 · AG

Human pluripotent stem cells

$1,573,768
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2023 · NS

GENE REPLACEMENT THERAPY IN HEMATOPOIETIC STEM CELLS

$1,573,711
Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2003 · HL

Northwestern University Center for Chromatin NanoImaging in Cancer (NU-CCNIC)

$1,573,684
Vadim Backman · Northwestern University · U54 · FY2024 · CA

PARKINSON'S DISEASE RESEARCH CENTER AT COLUMBIA

$1,573,609
Columbia University Health Sciences · P50 · FY2000 · NS

Institute of Human Virology Clinical Trials Unit

$1,573,448
William Albert Blattner · University Of Maryland Baltimore · U01 · FY2007 · AI

DNA Repair in Cancer Biology and Therapy

$1,573,413
Peter M Glazer · Yale University · P01 · FY2007 · CA

Molecular Mechanisms Of Glaucoma

$1,573,352
Stanislav I Tomarev · National Eye Institute · ZIA · FY2011 · EY

Immune Responses To Ocular Antigens

$1,573,352
Igal Gery · National Eye Institute · ZIA · FY2011 · EY

Identifying the spectrum of genetic alterations in high risk ALL

$1,573,220
Charles G. Mullighan · St. Jude Children'S Research Hospital · RC4 · FY2010 · CA

Regulation Of Immunopathology In Bacterial And Parasitic Disease

$1,573,205
Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI

Mechanisms of Esophageal Carcinogenesis

$1,573,148
Anil K Rustgi · Columbia University Health Sciences · P01 · FY2021 · CA

Understanding reservoir dynamics through analysis of viral decay processes

$1,573,078
Robert F Siliciano · Johns Hopkins University · P01 · FY2023 · AI

Understanding reservoir dynamics through analysis of viral decay processes

$1,573,078
Robert F Siliciano · Johns Hopkins University · P01 · FY2024 · AI

Understanding reservoir dynamics through analysis of viral decay processes

$1,573,078
Robert F Siliciano · Johns Hopkins University · P01 · FY2025 · AI

Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort

$1,572,951
Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2019 · AI

Discovery and validation of genetic variants affecting microglial activation in Alzheimer's disease

$1,572,761
Philip L De Jager · Columbia University Health Sciences · R01 · FY2024 · AG

Analgesic Drug for Local Delivery by Fluoroscopy

$1,572,160
Andreas S Beutler · Interventional Analgesix, Inc. · R44 · FY2021 · NS